Results 81 to 90 of about 642,073 (244)

Primary mucinous carcinoma of the skin: Report of a case

open access: yes, 2009
Primary mucinous eccrine carcinoma of the skin is a rare tumour. The most common site is the eyelid but other parts of the skin may be affected. We describe a recurrent primary mucinous carcinoma of the eyelid in a female and discuss its pathology.
EM Elamin   +5 more
core   +1 more source

Factors Associated With Receipt of Adjuvant Radiation in Locally Advanced Rectal Cancer

open access: yesJournal of Surgical Oncology, EarlyView.
ABSTRACT Background Neoadjuvant radiotherapy (RT) has been the standard of care for locally advanced rectal cancer (LARC) for over two decades. Adjuvant RT use in LARC represents a deviation from standard care and warrants further investigation. Objectives To identify factors associated with adjuvant RT utilization.
Maryam Sherwani   +4 more
wiley   +1 more source

Duodenal Mucinous Carcinoma: A Case Report

open access: yes대한영상의학회지, 2015
Duodenal mucinous carcinoma is exceedingly rare and a case report about duodenal mucinous carcinoma in a 61-year-old man mimicking pancreatic cystic neoplasm by radiological evaluation, endoscopy, and even surgical findings is presented.
Keum Nahn Jee
doaj   +1 more source

Clinicopathologic Characteristics of Colorectal Mucinous Carcinoma

open access: yes, 2003
Purpose: The aim of this study was to assess the clinicopathological characteristics and prognosis of colorectal mucinous carcinomas. Methods: 1,809 patients who underwent curative resection, between January 1989 and December 1999, for colorectal ...
김남규
core  

Targeted therapy for mucinous ovarian carcinoma: Evidence from clinical trials

open access: yes, 2022
Mucinous ovarian carcinoma is a rare subtype of epithelial ovarian cancer. Despite being a chemoresistant tumour type, surgical resection and chemotherapy are still the current standard for management.
Nugawela, D, Gorringe, KL
core   +1 more source

Pembrolizumab‐Induced Subacute Cutaneous Lupus Erythematosus: A Case Report

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Subacute cutaneous lupus erythematosus (SCLE) is an increasingly recognized cutaneous immune‐related adverse event of immune checkpoint inhibitors. We report an 83‐year‐old woman who developed pruritic annular and polycyclic plaques 10 weeks after starting pembrolizumab for oropharyngeal squamous cell carcinoma.
Sebastiano Posenato   +5 more
wiley   +1 more source

Effect of interferon-alpha on progression of cirrhosis to hepatocellular carcinoma: a retrospective cohort study.

open access: yes, 1998
BACKGROUND: There is debate about whether interferon-alpha treatment lowers the risk of progression to hepatocellular carcinoma in patients with chronic viral hepatitis and cirrhosis and whether any effect is limited to certain subgroups. We investigated
(INTERNATIONAL HEPATOCELLULAR CARCINOMA STUDY GROUP   +3 more
core  

Development and External Validation of a Postoperative Risk Score for Venous Thromboembolism in Epithelial Ovarian Cancer

open access: yesThe Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Venous thromboembolism (VTE), including deep vein thrombosis and pulmonary embolism, is a major complication in women with epithelial ovarian cancer (EOC). We aimed to develop and externally validate an early postoperative risk score to identify EOC patients at increased risk of VTE after debulking surgery.
Qiu‐Lin Cui   +6 more
wiley   +1 more source

Pure and Mixed Mucinous Carcinoma of the Breast

open access: yesEuropean Journal of Breast Health, 2013
Objective: Mucinous carcinoma of the breast is relatively rare and the prevalence of its pure form among all carcinomas of the breast is 2%. Its pure and mixed types have been defined.
Ebubekir Gündeş   +3 more
doaj   +1 more source

Cystic Lesions of the Pancreas [PDF]

open access: yes, 2014
With the increasing use of abdominal imaging, cystic lesions of the pancreas are being more frequently detected. These lesions may carry a significant premalignant potential.
Azzopardi, Neville
core  

Home - About - Disclaimer - Privacy